rs143461704
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001283009.2(RTEL1):c.245C>T(p.Pro82Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000942 in 1,613,490 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001283009.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTEL1 | NM_001283009.2 | c.245C>T | p.Pro82Leu | missense_variant | 3/35 | ENST00000360203.11 | NP_001269938.1 | |
RTEL1-TNFRSF6B | NR_037882.1 | n.1072C>T | non_coding_transcript_exon_variant | 3/38 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTEL1 | ENST00000360203.11 | c.245C>T | p.Pro82Leu | missense_variant | 3/35 | 5 | NM_001283009.2 | ENSP00000353332 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152156Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000299 AC: 75AN: 250654Hom.: 0 AF XY: 0.000258 AC XY: 35AN XY: 135638
GnomAD4 exome AF: 0.000998 AC: 1459AN: 1461334Hom.: 2 Cov.: 32 AF XY: 0.000970 AC XY: 705AN XY: 726986
GnomAD4 genome AF: 0.000401 AC: 61AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.000323 AC XY: 24AN XY: 74332
ClinVar
Submissions by phenotype
Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 23, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 82 of the RTEL1 protein (p.Pro82Leu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with aplastic anemia (PMID: 29344583, 30523342). ClinVar contains an entry for this variant (Variation ID: 436585). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on RTEL1 function (PMID: 29344583). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 07, 2022 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 15, 2016 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2022 | The c.245C>T (p.P82L) alteration is located in exon 3 (coding exon 2) of the RTEL1 gene. This alteration results from a C to T substitution at nucleotide position 245, causing the proline (P) at amino acid position 82 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Dyskeratosis congenita, autosomal dominant 1 Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jun 15, 2020 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 13, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies are inconclusive: normal overall telomere length but erosion of the 3' overhang, and normal regulation of TRF2 in patient peripheral blood cells but increased TRF2 expression in a 293T cell line (PMID: 29344583); Observed in an individual with aplastic anemia and in their unaffected brother, as well as in an unrelated individual with acute myelogenous leukemia and in their brother with thrombocytopenia (PMID: 29344583, 30523342); This variant is associated with the following publications: (PMID: 29344583, 30523342, 36496180) - |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Jun 02, 2022 | This RTEL1 missense variant has been reported in the literature in an individual with aplastic anemia and the individual's sibling with thrombocytopenia. This variant (rs143461704) is rare (<0.1%) in a large population dataset (gnomAD v3.1.2: 61/152156 total alleles; 0.04%; no homozygotes), and has been reported in ClinVar (Variation ID 436585). Of three bioinformatics tools queried, one predicts that the substitution would be damaging, while two predict that it would be tolerated. While the proline residue at this position is evolutionarily conserved across many of the species assessed, leucine is present at this position in multiple species. Functional studies performed were inconclusive. We consider the clinical significance of c.245C>T to be uncertain at this time. - |
RTEL1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 23, 2024 | The RTEL1 c.245C>T variant is predicted to result in the amino acid substitution p.Pro82Leu. This variant has been reported in an individual with moderate aplastic anemia and mitral valve prolapse (Marsh et al. 2018. PubMed ID: 29344583). This variant was also reported in two siblings with aplastic anemia and normal telomere length (Patients NIH078 and NIH079 in Supplemental Table S3, Gutierrez-Rodrigues et al. 2019. PubMed ID: 30523342). This variant is reported in 0.061% of alleles in individuals of European (Non-Finnish) descent in gnomAD and has been interpreted as uncertain in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/436585). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at